Company intelligence / Profile preview

BRF

Shreveport, Louisiana, United Statesbrf-global.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

BRF operates the Center for Molecular Imaging and Therapy (CMIT), a leading center for radiopharmaceutical production and clinical imaging. It has served over 46,000 patients since inception. The new $14.2 million CMIT facility expands capabilities into novel radiopharmaceuticals targeting major diseases including cardiovascular conditions and various cancers.

Therapeutic areas: EndocrinologyOncologyCardiovascularNeurology
Modalities: Radiopharmaceuticals
Industry: Biotech

Partnerships

Collaborates with local hospitals/universities such as LSU Health Shreveport.

Beyond the preview

Go deeper on BRF.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BRF.

Explore the full profile